Graham served as Chairman of
the Department of Chemistry at
Oxford University. Throughout his
career, he has been involved in the
commercialisation of technologies
where he was a director of the
University of Oxford’s technology
transfer company. He was also
involved with the Wellcome Trust in a similar capacity. He co-founded Oxford Molecular Group plc., InhibOx Ltd. and Oxford Drug Design Ltd. He was a main board director, now venture partner, of IP Group plc., the listed intellectual property commercialisation company.